Skip to main content

Colon Conduit Urinary Diversion

A colon conduit is an incontinent diversion using an isolated colonic segment to drain urine from the ureters into an abdominal appliance. Transverse, descending or sigmoid colon may be used according to tissue quality, vascular supply, ureteral reach and the need for fecal diversion. It is an alternative when ileum is unsuitable; no colonic segment is universally preferred.[1][2]

Selection and segment choice​

SituationPlanning considerations
Prior pelvic radiationReview the actual field and bowel injury. Healthy transverse colon may be available above the treated area, but colon is not intrinsically radiation-resistant
Existing or planned colostomyA suitable colonic segment can provide the urinary conduit with a separate proximal fecal stoma, avoiding an additional bowel-to-bowel anastomosis
Limited small-bowel reservePreserve remaining absorptive bowel when feasible; assess nutritional status and the effect of excluding colon as well
Inflammatory bowel disease or prior colonic surgeryEstablish whether the proposed segment and its blood supply are healthy; small-bowel Crohn's disease does not automatically make colon suitable
Renal or hepatic impairmentUrine-exposed colon still produces a metabolic burden; assess severity and alternatives rather than assuming a colon conduit avoids acidosis

These decisions need individualized reconstructive and, when relevant, colorectal planning. The historical transverse-conduit literature supports feasibility after radiation, not a modern comparative guarantee of fewer complications.[3][4][2][5]

An isolated colon conduit does not use the anal sphincter for continence. Ureterosigmoidostomy and staged ureterocolocolostomy are different operations; their anal-function prerequisites should not be copied into this procedure's contraindications.

Operative framework​

  1. Select viable bowel and a preserved vascular pedicle. Determine the length needed for tension-free ureteral implantation and stoma reach. Prior radiation, scarring, mesenteric injury or active bowel disease may make a proposed segment unsuitable.
  2. Plan both bowel ends. An isolated segment ordinarily requires restoration of intestinal continuity. When fecal diversion is also required, an appropriately designed proximal colostomy can avoid that bowel-to-bowel anastomosis.
  3. Preserve ureteral perfusion and avoid tension or angulation. Refluxing implantation can be separate or use a common ureteral plate; “refluxing” is not synonymous with Wallace. A nonrefluxing submucosal tunnel introduces additional requirements for caliber and freedom from compression.
  4. Mature a well-perfused, accessible stoma. Confirm unobstructed drainage and a feasible appliance surface. Coordinate the siting of any fecal stoma.

These are shared principles, not a fixed-length or universal vessel-division recipe. See the colon shuffle for colostomy conversion and upper-tract reconstruction principles for ureteral handling.[6][7][5]

The older Cochrane review found insufficient randomized evidence to establish a best diversion or implantation technique; its search ended in October 2011. It does not supply a 15–20 cm operative rule or prove nonrefluxing implantation superior. Dagen's 1980 report described two stenosis cases; its background 8–10% figure is not a contemporary pooled stricture rate.[8][7]

Contemporary outcomes​

Hebert's 2026 retrospective study included 179 patients from four institutions, treated during 1990–2022. Prior radiation and abdominal surgery were common; the cohort combined colon conduits with anastomosis, with colostomy and with colostomy switch.[1]

OutcomeReported result
High-grade complications within 30 days28.5%
High-grade complications during days 30–9014.5%
Mortality within 90 days4.5%
Reintervention within 90 days30.2%
Later ureteral stent or nephrostomy requirement16.8%; this is not synonymous with anastomotic stricture

Source: Hebert 2026.[1] Albumin ≥3.2 g/dL was associated with fewer 30–90-day high-grade complications (HR 0.18). This is an observational association, not proof that treating to that threshold prevents complications. Concurrent colonic anastomosis was not associated with worse 30-day outcomes; that result does not establish equivalence of the operative strategies.

Comparisons with ileal conduit​

Hagemans retrospectively compared 214 ileal and 45 colon conduits after rectal-cancer exenteration. Ileus occurred in 21% versus 7%; wound infection in 14% versus 31%, although the wound association did not persist in adjusted analysis. Nine ileal-conduit patients had an ileo-ileal anastomotic leak. Avoiding that anastomosis avoids a leak at that particular site, not all bowel leaks, fistulas or major complications. Other selected outcomes were not statistically different; nonrandomized selection limits comparative conclusions.[9]

Pycha's prospective, nonrandomized comparison included 55 ileal conduits, 34 colon conduits and 41 ureterostomies. Different complication patterns in these selected groups do not establish a universally safer bowel segment.[10]

Metabolic and late complications​

Urine exposure can cause hyperchloremic metabolic acidosis, electrolyte abnormalities and other intestinal-diversion consequences. Severity depends on renal reserve, bowel surface/contact time and drainage. Alkali and electrolyte treatment should follow measured abnormalities and the pharmacology guidance.[11][2]

Alemozaffar's 41-patient distal-colon series reported, at ≥90 days, hypokalemia in 39%, hyperchloremia in 24.4% and metabolic acidosis in 34.1%. It also recorded ureterocolonic strictures in 4/41. These are one cohort's time-specific outcomes, not universal colon-conduit rates. Early ileus, bowel obstruction and an enterocutaneous fistula still occurred despite avoiding small-bowel anastomosis.[4]

Shimko's longer-term report combined ileal and colon conduits: 643/1,057 patients developed diversion-related complications, with 2.3 events per affected patient. The 15.5-year median follow-up applied to the 213 survivors, not the entire cohort. The study supports prolonged follow-up but cannot supply colon-only complication probabilities.[12]

Monitor renal function, electrolytes/acid–base status, upper-tract drainage, infection symptoms and stoma function. B12 risk also depends on prior ileal resection, nutrition and other causes; EAU recommends annual B12 measurement after bowel diversion. New hydronephrosis warrants assessment for obstruction even when a nonrefluxing implantation was used.[7][13]

See Also​

References​

1. Hebert KJ, Swinney S, Johnson R, et al. "Outcomes After Colon Conduit Urinary Diversion: A Multi-Institutional Retrospective Study from the Reconstruction and Diversion: Improving Outcomes Group." J Urol. 2026;215(5):621–32. doi:10.1097/JU.0000000000004935

2. European Association of Urology. EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. 2026. Urinary diversion and patient selection. Guideline.

3. Schmidt JD, Hawtrey CE, Buchsbaum HJ. "Transverse Colon Conduit: A Preferred Method of Urinary Diversion for Radiation-Treated Pelvic Malignancies." J Urol. 1975;113(3):308–13. doi:10.1016/s0022-5347(17)59469-0

4. Alemozaffar M, Nam CS, Said MA, et al. "Avoiding the Need for Bowel Anastomosis During Pelvic Exenteration — Urinary Sigmoid or Descending Colon Conduit — Short and Long-Term Complications." Urology. 2019;129:228–33. doi:10.1016/j.urology.2019.03.015

5. Theva DP, Kuhnen A, Babayan RK, Katz MH. Concurrent urinary and bowel diversion: Surgical modification with sigmoid colon that avoids a bowel anastomosis. Int Braz J Urol. 2020;46(1):108–115. doi:10.1590/S1677-5538.IBJU.2019.0194. Full text.

6. Davis BE, Noble MJ. "Simplified Urinary Diversion in Patients with Preexisting or Imminent Colostomy." J Urol. 1992;147(5):1245–7. doi:10.1016/s0022-5347(17)37529-8

7. Dagen JE, Sanford EJ, Rohner TJ. "Complications of the Non-Refluxing Colon Conduit." J Urol. 1980;123(4):585–7. doi:10.1016/s0022-5347(17)56031-0

8. Cody JD, Nabi G, Dublin N, et al. "Urinary Diversion and Bladder Reconstruction / Replacement Using Intestinal Segments for Intractable Incontinence or Following Cystectomy." Cochrane Database Syst Rev. 2012;(2):CD003306. doi:10.1002/14651858.CD003306.pub2

9. Hagemans JAW, Voogt ELK, Rothbarth J, et al. "Outcomes of Urinary Diversion After Surgery for Locally Advanced or Locally Recurrent Rectal Cancer with Complete Cystectomy; Ileal and Colon Conduit." Eur J Surg Oncol. 2020;46(6):1160–6. doi:10.1016/j.ejso.2020.02.021

10. Pycha A, Comploj E, Martini T, et al. "Comparison of Complications in Three Incontinent Urinary Diversions." Eur Urol. 2008;54(4):825–32. doi:10.1016/j.eururo.2008.04.068

11. Roth JD, Koch MO. "Metabolic and Nutritional Consequences of Urinary Diversion Using Intestinal Segments to Reconstruct the Urinary Tract." Urol Clin North Am. 2018;45(1):19–24. doi:10.1016/j.ucl.2017.09.007

12. Shimko MS, Tollefson MK, Umbreit EC, et al. "Long-Term Complications of Conduit Urinary Diversion." J Urol. 2011;185(2):562–7. doi:10.1016/j.juro.2010.09.096

13. European Association of Urology. EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. 2026. Functional follow-up. Guideline.